XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.healtheconomics.com/industry-news/shafrin-icer-tackling-pressing-issue-with-value-over-time-reports60%Hourly2019-02-28 14:29
https://www.healtheconomics.com/industry-news/podcast-spotlights-artificial-intelligence-in-oncology60%Hourly2019-02-27 15:38
https://www.healtheconomics.com/government/report-pharma-execs-largely-dodged-questions60%Hourly2019-02-27 15:44
https://www.healtheconomics.com/government/fendrick-klein-back-drug-rebate-proposal60%Hourly2019-02-27 14:18
https://www.healtheconomics.com/industry-news/firstword-report-explores-influence-of-icer60%Hourly2019-02-27 13:53
https://www.healtheconomics.com/industry-news/real-world-evidence-and-value-based-contracting-swipe-left-or-swipe-right60%Hourly2019-02-27 13:33
https://www.healtheconomics.com/government/astrazeneca-ceo-urges-government-action-on-drug-pricing60%Hourly2019-02-26 20:57
https://www.healtheconomics.com/industry-news/tufts-cevr-hiring-grad-school-students-for-summer-internship60%Hourly2019-02-26 20:51
https://www.healtheconomics.com/specialty-pharmacy/article-obc-puts-patient-first60%Hourly2019-02-26 20:42
https://www.healtheconomics.com/government/pharma-execs-warn-against-heavy-congressional-intervention-for-drug-prices60%Hourly2019-02-26 20:25
https://www.healtheconomics.com/industry-news/peschin-icers-methodology-is-unscientific-and-discriminatory60%Hourly2019-02-26 18:35
https://www.healtheconomics.com/industry-news/ispors-women-in-heor-launch-linkedin-group60%Hourly2019-02-26 18:18
https://www.healtheconomics.com/industry-news/ispor-offering-webinar-on-top-10-heor-trends60%Hourly2019-02-26 14:51
https://www.healtheconomics.com/government/pharma-execs-to-testify-on-drug-prices-today60%Hourly2019-02-26 14:30
https://www.healtheconomics.com/specialty-pharmacy/report-estimates-of-sma-drugs-could-fuel-drug-pricing-debate60%Hourly2019-02-26 00:18
https://www.healtheconomics.com/specialty-pharmacy/blog-post-spotlights-challenges-for-health-system-for-new-therapies60%Hourly2019-02-25 23:33
https://www.healtheconomics.com/government/fda-flatiron-health-expand-research-collaboration60%Hourly2019-02-25 23:11
https://www.healtheconomics.com/industry-news/icer-to-review-additive-cardiovascular-disease-therapies60%Hourly2019-02-25 22:54
https://www.healtheconomics.com/industry-news/article-spotlights-challenges-in-assessing-value-of-one-time-gene-therapies60%Hourly2019-02-25 22:52
https://www.healtheconomics.com/industry-news/nice-report-cancer-drugs-priced-according-to-effectiveness-could-be-boon-to-nhs60%Hourly2019-02-25 22:50
https://www.healtheconomics.com/industry-news/icer-recommends-significant-reduction-on-spinraza-zolgensma-price-tags60%Hourly2019-02-25 22:49
https://www.healtheconomics.com/government/avalere-healths-sloan-talks-drug-rebates-on-podcast60%Hourly2019-02-25 22:10
https://www.healtheconomics.com/government/proposed-title-x-changes-spur-criticism60%Hourly2019-02-25 22:10
https://www.healtheconomics.com/industry-news/icer-spinraza-zolgensma-offer-substantial-health-benefits60%Hourly2019-02-22 21:42
https://www.healtheconomics.com/industry-news/opinion-abandon-qaly-metric-in-cost-effectiveness-reviews60%Hourly2019-02-22 21:33
https://www.healtheconomics.com/industry-news/unsealed-testimony-reveals-details-about-amazon-berkshire-and-j-p-morgan-health-venture60%Hourly2019-02-22 17:17
https://www.healtheconomics.com/industry-news/column-tap-pharmacists-to-help-wrangle-drug-prices60%Hourly2019-02-22 16:30
https://www.healtheconomics.com/government/stat-offering-webinar-on-congress-drug-prices60%Hourly2019-02-22 16:15
https://www.healtheconomics.com/government/the-7-pharma-execs-set-to-testify-before-congress60%Hourly2019-02-22 15:31
https://www.healtheconomics.com/government/government-drug-spending-to-accelerate-hit-6-1-per-year-by-202060%Hourly2019-02-21 15:37
https://www.healtheconomics.com/government/gottlieb-says-government-intervention-possible-for-states-allowing-vaccine-exemptions60%Hourly2019-02-21 15:11
https://www.healtheconomics.com/industry-news/drugs-375k-price-tag-leads-to-rationing-criticism60%Hourly2019-02-21 14:49
https://www.healtheconomics.com/industry-news/report-health-expenditures-projected-to-grow-5-5-per-year60%Hourly2019-02-21 16:09
https://www.healtheconomics.com/government/fda-gets-significant-boost-to-budget60%Hourly2019-02-18 21:19
https://www.healtheconomics.com/government/former-legislator-honors-dingell-his-health-politics60%Hourly2019-02-17 16:02
https://www.healtheconomics.com/industry-news/hcci-health-spending-rises-despite-little-change-in-utilization60%Hourly2019-02-16 21:54
https://www.healtheconomics.com/industry-news/article-longitudinal-database-offers-number-of-benefits60%Hourly2019-02-15 17:06
https://www.healtheconomics.com/industry-news/policyed-announces-new-video-series-on-economic-fundamentals60%Hourly2019-02-15 16:47
https://www.healtheconomics.com/industry-news/icer-releases-final-new-evidence-update-for-alirocumab60%Hourly2019-02-15 16:33
https://www.healtheconomics.com/industry-news/kottler-bolster-adherence-to-increase-revenue-keep-health-costs-under-control60%Hourly2019-02-15 16:15
https://www.healtheconomics.com/industry-news/nice-provides-first-advice-on-patient-preference-study-design60%Hourly2019-02-15 15:44
https://www.healtheconomics.com/industry-news/optumrx-wants-pharma-to-make-chages-to-rebates60%Hourly2019-02-15 16:36
https://www.healtheconomics.com/industry-news/ama-president-slams-insurers-for-surprise-billing60%Hourly2019-02-14 17:19
https://www.healtheconomics.com/industry-news/research-standardized-method-to-measure-mma-is-needed60%Hourly2019-02-14 17:00
https://www.healtheconomics.com/industry-news/podcast-spotlights-chargemasters60%Hourly2019-02-14 16:35
https://www.healtheconomics.com/industry-news/ispor-issues-call-for-reviewers-for-latin-america-conference60%Hourly2019-02-14 15:52
https://www.healtheconomics.com/industry-news/study-interest-in-vbcs-greater-than-previously-thought60%Hourly2019-02-13 22:05
https://www.healtheconomics.com/industry-news/unitedhealthcare-seeks-21-month-notice-for-drug-price-hikes60%Hourly2019-02-13 16:25
https://www.healtheconomics.com/industry-news/once-free-drug-to-cost-300000-plus-per-year60%Hourly2019-02-13 16:06
https://www.healtheconomics.com/industry-news/value-communication-is-not-fit-for-purpose-in-biopharma60%Hourly2019-02-13 14:19
https://www.healtheconomics.com/industry-news/efforts-to-bolster-pros-expected-to-play-key-role-in-cancer-drug-development60%Hourly2019-02-12 15:04
https://www.healtheconomics.com/industry-news/article-price-drops-on-praluent-repatha-boon-for-patients60%Hourly2019-02-12 15:54
https://www.healtheconomics.com/government/amcp-spotlights-recent-managed-care-news60%Hourly2019-02-12 14:03
https://www.healtheconomics.com/industry-news/column-proposes-one-and-done-solution-for-drug-patents60%Hourly2019-02-12 13:44
https://www.healtheconomics.com/industry-news/sandozs-hendriks-impact-of-biosimilars-in-insulin-market-could-be-significant60%Hourly2019-02-11 22:15
https://www.healtheconomics.com/industry-news/phrma-foundation-to-fund-new-centers-of-excellence60%Hourly2019-02-11 21:31
https://www.healtheconomics.com/government/column-pharma-execs-would-be-foolish-not-to-testify60%Hourly2019-02-11 21:22
https://www.healtheconomics.com/industry-news/blog-himss-part-of-larger-ecosystem60%Hourly2019-02-11 18:14
https://www.healtheconomics.com/industry-news/do-hospital-mergers-really-improve-health60%Hourly2019-02-11 17:38
https://www.healtheconomics.com/industry-news/analysis-suggests-income-correlated-to-filled-prescriptions60%Hourly2019-02-10 17:09
https://www.healtheconomics.com/industry-news/healtheconomics-com-announces-new-rate-for-job-listings60%Hourly2019-02-09 00:17
https://www.healtheconomics.com/industry-news/jj-to-include-list-prices-in-tv-ads60%Hourly2019-02-08 15:58
https://www.healtheconomics.com/industry-news/podcast-talks-operationalizing-innovation60%Hourly2019-02-07 16:25
https://www.healtheconomics.com/industry-news/iqvias-doyle-talks-shared-value-across-all-stakeholders60%Hourly2019-02-07 15:45
https://www.healtheconomics.com/government/leonard-discusses-npcs-response-to-hhs-rfi60%Hourly2019-02-07 15:10
https://www.healtheconomics.com/industry-news/icer-sets-out-against-unjustified-price-increases-in-new-report60%Hourly2019-02-07 14:31
https://www.healtheconomics.com/government/article-highlights-health-spending-in-u-s-taiwan60%Hourly2019-02-06 21:08
https://www.healtheconomics.com/industry-news/tufts-medical-center-announces-new-center60%Hourly2019-02-16 05:54
https://www.healtheconomics.com/government/pbms-defend-against-trump-administrations-proposal60%Hourly2019-02-06 20:26
https://www.healtheconomics.com/government/trump-on-drug-prices-we-must-do-more60%Hourly2019-02-06 14:24
https://www.healtheconomics.com/industry-news/amcp-announces-updated-fundamentals-of-managed-care-pharmacy-course60%Hourly2019-02-05 14:52
https://www.healtheconomics.com/government/trump-expected-to-talk-health-costs-at-sotu60%Hourly2019-02-04 17:00
https://www.healtheconomics.com/industry-news/himss19-to-focus-on-transparency-data-exchange60%Hourly2019-02-04 16:16
https://www.healtheconomics.com/government/new-paper-spotlights-2018-trends-in-specialty-drugs60%Hourly2019-02-04 15:46
https://www.healtheconomics.com/government/azar-rebates-proposal-is-exit-from-broken-status-quo60%Hourly2019-02-04 15:59
https://www.healtheconomics.com/government/sachs-looks-at-possible-implications-of-rebates-proposal60%Hourly2019-02-03 15:39
https://www.healtheconomics.com/industry-news/healthcare-triages-carroll-seeking-postdoc60%Hourly2019-02-02 14:47
https://www.healtheconomics.com/industry-news/study-payer-experts-say-pie-needs-legislative-safe-harbor60%Hourly2019-02-02 14:24
https://www.healtheconomics.com/government/trumps-rebate-proposal-receives-mixed-reactions60%Hourly2019-02-01 17:55
https://www.healtheconomics.com/industry-news/reuters-cvs-adds-teva-lilly-migraine-drugs60%Hourly2019-02-01 17:18
https://www.healtheconomics.com/industry-news/report-phrma-could-accept-inflation-limits60%Hourly2019-02-01 16:57
https://www.healtheconomics.com/government/trump-administration-proposal-would-end-pharma-rebates-to-pbms60%Hourly2019-02-01 14:41